Survival rates for non-Hodgkin lymphoma. The overall 5-year relative survival rate for people with NHL is 70%, and the 10-year relative survival rate is 60%. But it's important to keep in mind that survival rates can vary widely for different types and stages of lymphoma.
Five-year conditional relative survival was computed for every additional year of survival up to 16 years after diagnosis, according to entity, grade, gender, age, and Ann Arbor stage. The prognosis for survivors of indolent B-cell non-Hodgkin lymphoma improved slightly with each additional year survived up to 91%.
The type and size of the lymphoma is also important to establish prognosis because smaller tumors are easier to treat, as well as B–cell lymphomas and .
Rituximab has improved survival of diffuse large B–cell lymphoma (DLBCL). Four risk groups were identified that predicted 5-year survival rates of 73%, 51%,